<DOC>
	<DOCNO>NCT00973700</DOCNO>
	<brief_summary>This study evaluate safety immunogenicity different combination A/H1N1 S-OIV ( swine flu ) vaccine healthy young child , adolescent , adult .</brief_summary>
	<brief_title>Safety Immunogenicity A/H1N1-SOIV ( Swine Flu ) Vaccine With Without Adjuvant Children , Adolescents Adults ( 3 64 Years )</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>MF59 oil emulsion</mesh_term>
	<criteria>Children , adolescent , adult 3 64 year age good health determine medical history , physical assessment clinical judgement investigator without influenza within past 6 month . History serious disease . History serious reaction follow administration vaccine hypersensitivity vaccine component . Known suspect impairment/alteration immune function . Receipt plan receipt seasonal trivalent influenza vaccine within 1 week study vaccination . For additional entry criterion , please refer protocol .</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Swine Flu</keyword>
	<keyword>Flu</keyword>
	<keyword>Vaccine</keyword>
	<keyword>Adjuvant</keyword>
</DOC>